Staphylococcus Aureus
80
5
7
49
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
13 trials with published results (16%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
10.0%
8 terminated out of 80 trials
86.0%
-0.6% vs benchmark
14%
11 trials in Phase 3/4
27%
13 of 49 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 49 completed trials
Clinical Trials (80)
Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Decolonization Efficacy of Polyhexanide vs. Mupirocin
Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome
Evaluation of the Antibiofilmogramme® Test During Diabetic Foot Infections
Role of the NLRP3 Inflammasome in Escherichia Coli and Staphylococcus Aureus Bacteria
Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia
Staph Household Intervention for Eradication (SHINE)
Staphylococcal Toxins in Atopic Dermatitis and Eczema Herpeticum
Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant
Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3
The Foot in Your Nose Study: Links Between Nasal Staphylococcus Aureus Colonies and Diabetic Foot Lesion Infections
Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates
Impact of 18 FDG PET/CT on the Management of Patients With Staphylococcus Aureus Bloodstream Infection
Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP
Mupirocin-Iodophor ICU Decolonization Swap Out Trial
A Prospective Cohort Pilot Study of the Clinical and Molecular Epidemiology of Staphylococcus Aureus in Pregnant Women at the Time of Group B Streptococcal Screening in a Large Urban Medical Center in Chicago, IL USA
A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2
First-in-man Single-dose and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy ofHY-133
Evaluation of a Diagnostic Device for Detection of Nasal Staphylococcus Aureus